These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8578832)

  • 1. Induction of systemic immune responses to measles virus synthetic peptides administered intranasally.
    Hathaway LJ; Partidos CD; Vohra P; Steward MW
    Vaccine; 1995 Nov; 13(16):1495-500. PubMed ID: 8578832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.
    Obeid OE; Partidos CD; Howard CR; Steward MW
    J Virol; 1995 Mar; 69(3):1420-8. PubMed ID: 7531779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological analysis of the protective responses to the chimeric synthetic peptide representing T- and B-cell epitopes from the fusion protein of measles virus.
    Obeid OE; Stanley CM; Steward MW
    Virus Res; 1996 Jun; 42(1-2):173-80. PubMed ID: 8806185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against measles virus-induced encephalitis by antibodies from mice immunized intranasally with a synthetic peptide immunogen.
    Hathaway LJ; Obeid OE; Steward MW
    Vaccine; 1998; 16(2-3):135-41. PubMed ID: 9607021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies.
    El Kasmi KC; Fillon S; Theisen DM; Hartter H; Brons NH; Muller CP
    J Gen Virol; 2000 Mar; 81(Pt 3):729-35. PubMed ID: 10675410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes.
    Levi R; Aboud-Pirak E; Leclerc C; Lowell GH; Arnon R
    Vaccine; 1995 Oct; 13(14):1353-9. PubMed ID: 8585293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide.
    Partidos CD; Vohra P; Steward MW
    Virology; 1996 Jan; 215(1):107-10. PubMed ID: 8553582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mimotope from a solid-phase peptide library induces a measles virus-neutralizing and protective antibody response.
    Steward MW; Stanley CM; Obeid OE
    J Virol; 1995 Dec; 69(12):7668-73. PubMed ID: 7494275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides.
    Partidos CD; Vohra P; Steward MW
    Immunology; 1996 Feb; 87(2):179-85. PubMed ID: 8698377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the contribution of CTL epitopes in the immunobiology of morbillivirus infection.
    Beauverger P; Cardoso AI; Daviet L; Buckland R; Wild TF
    Virology; 1996 May; 219(1):133-9. PubMed ID: 8623522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
    Olszewska W; Obeid OE; Steward MW
    Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of virus crossreactivity and neutralisation after immunisation with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein.
    El Kasmi KC; Theisen D; Brons NH; Muller CP
    Mol Immunol; 1998 Oct; 35(14-15):905-18. PubMed ID: 9881686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins.
    Partidos CD; Stanley CM; Steward MW
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1293-9. PubMed ID: 1710646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.
    Lairmore MD; DiGeorge AM; Conrad SF; Trevino AV; Lal RB; Kaumaya PT
    J Virol; 1995 Oct; 69(10):6077-89. PubMed ID: 7545241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotype-specific and canine distemper virus cross-reactive H-2Kk-restricted cytotoxic T lymphocyte epitopes in the measles virus nucleoprotein.
    Beauverger P; Chadwick J; Buckland R; Wild TF
    Virology; 1994 Aug; 203(1):172-7. PubMed ID: 7518168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides.
    Partidos CD; Obeid OE; Steward MW
    Immunology; 1992 Oct; 77(2):262-6. PubMed ID: 1385315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of a flanking sequence on the immune response to a B and a T cell epitope from the fusion protein of measles virus.
    Partidos CD; Steward MW
    J Gen Virol; 1992 Aug; 73 ( Pt 8)():1987-94. PubMed ID: 1379626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the neutralizing antibody response to the measles virus using synthetic peptides of the haemagglutinin protein.
    Muller CP; Schroeder T; Tu R; Brons NH; Jung G; Schneider F; Wiesmüller KH
    Scand J Immunol; 1993 Nov; 38(5):463-71. PubMed ID: 7694357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides.
    Partidos C; Stanley C; Steward M
    Eur J Immunol; 1992 Oct; 22(10):2675-80. PubMed ID: 1382995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia-measles recombinant viruses.
    Galletti R; Beauverger P; Wild TF
    Vaccine; 1995 Feb; 13(2):197-201. PubMed ID: 7625116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.